
Childhoods End (O) price today
Not listedMarket sentiment
Live O chart
Childhoods End (O) price details

Childhoods End price history
Childhoods End technical analysis
Childhoods End (O) sentiment
About Childhoods End
What is O?
$O is a dual-chain token deployed on Base (ERC-20) and BNB Smart Chain (BEP-20). The token's official documentation and market statistics (as of June 18, 2026) are available at o1.exchange.
Official links
Social media and community
FAQ
What is the current price of Childhoods End (O) in USD?
What is the market capitalization of Childhoods End (O)?
What is the circulating supply of Childhoods End (O)?
What factors influence the price of Childhoods End (O)?
Is Childhoods End (O) a good investment?
Where can I buy Childhoods End (O)?
What are the typical fees when buying Childhoods End (O)?
What are some technical indicators used for analyzing Childhoods End (O)?
Global prices
Childhoods End news
Why Bitcoin’s quantum security upgrade may take years
The Industry Is Not Bad, But the $350 Billion Lost by ETH and SOL Is the Root Cause of Industry Pessimism
Felipe Montealegre believes that stablecoins, tokenized assets, and on-chain finance are taking shape, and the industry's revenue has not collapsed. The real pain for practitioners comes from the balance sheet: this year, cash inflows are about $26.6 billion, but since last October, ETH and SOL alon...
Prediction: These Will Be AMD’s and Nvidia’s Stock Prices by 2028
Shares of both semiconductor companies can soar impressively, but one of them seems primed for bigger gains.
Crypto: Netflix Series on FTX Sparks Reactions from CZ and Vitalik Buterin
Solana upgrades to mainnet 1.0 as Foundation takes majority CoinGecko stake
IOSCO Warns of 'Quantum Delay' and Assesses Readiness for Quantum Threat
Deribit outage hit Bitcoin hedgers on Coinbase
Deribit’s Nov. 20 outage disrupted Bitcoin and Ether perpetuals across Coinbase and Deribit. Coinbase said its separate US derivatives were unaffected.
Johnson & Johnson Is on Track for $101 Billion in 2026 Sales. Is This Dividend King Still a Buy?
J&J is a healthcare giant performing very well right now, but it won't be a great fit for every investor.



















